Neurochemical Research

, Volume 41, Issue 1–2, pp 298–306 | Cite as

Uptake and Toxicity of Hemin and Iron in Cultured Mouse Astrocytes

  • Jessica E. Owen
  • Glenda M. Bishop
  • Stephen R. Robinson
Original Paper


Hemin is a breakdown product of the blood protein, hemoglobin and is responsible for much of the secondary damage caused following a hemorrhagic stroke. Hemin is toxic to cultured astrocytes and it is thought that this toxicity is due to iron that is liberated when hemin is degraded. However, free iron applied to astrocytes is not toxic and the reason for this discrepancy is unknown. The present study exposed primary astrocyte cultures from neonatal mice to hemin-iron (25 µM hemin) or non-hemin iron (25 µM ferric ammonium citrate; FAC) for 12 or 24 h. Perls’ and Turnbull’s staining, as well as measures of cell viability and iron accumulation, were used to assess the valency, solubility and distribution of iron within cells. While cells accumulated similar amounts of iron from both sources, hemin was shown to be highly toxic to astrocytes, whereas FAC was not. Iron released by the degradation of hemin was present in both valencies (Fe2+ and Fe3+), was mostly soluble and did not induce ferritin expression in most cells, whereas non-hemin iron (from FAC) was present in astrocytes almost exclusively as insoluble Fe3+ and it induced widespread ferritin expression. These results show that the cellular mechanisms for processing hemin-iron and non-hemin iron are very different. The data suggest that hemin-iron has a greater potential to damage astrocytes by participating in unregulated redox reactions.


Brain Fenton chemistry Ferritin Astrocytes Heme oxygenase Oxidative stress 



We acknowledge the School of Psychology and Psychiatry at Monash University, Melbourne Australia, as some data for this project was collected while the investigators were based at that University.


  1. 1.
    Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP (2009) Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 40:2068–2072CrossRefPubMedGoogle Scholar
  2. 2.
    Qureshi AI, Mendelow AD, Hanley DF (2009) Intracerebral haemorrhage. Lancet 373:1632–1644CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Huffman LJ, Miles PR, Shi X, Bowman L (2000) Hemoglobin potentiates the production of reactive oxygen species by alveolar macrophages. Exp Lung Res 26:203–217CrossRefPubMedGoogle Scholar
  4. 4.
    Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM (1991) Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 11:1700–1711CrossRefPubMedGoogle Scholar
  5. 5.
    Dang TN, Robinson SR, Dringen R, Bishop GM (2011) Uptake, metabolism and toxicity of hemin in cultured neurons. Neurochem Int 58:804–811CrossRefPubMedGoogle Scholar
  6. 6.
    Dang TN, Bishop GM, Dringen R, Robinson SR (2011) The metabolism and toxicity of hemin in astrocytes. Glia 59:1540–1550CrossRefPubMedGoogle Scholar
  7. 7.
    Nagababu E, Rifkind JM (2004) Heme degradation by reactive oxygen species. Antioxid Redox Signal 6:967–978CrossRefPubMedGoogle Scholar
  8. 8.
    Gaasch JA, Lockman PR, Geldenhuys WJ, Allen DD, Van Der Schyf CJ (2007) Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res 32:1196–1208CrossRefPubMedGoogle Scholar
  9. 9.
    Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA (2002) Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 24:184–187CrossRefPubMedGoogle Scholar
  10. 10.
    Thompson KJ, Shoham S, Connor JR (2001) Iron and neurodegenerative disorders. Brain Res Bull 55:155–164CrossRefPubMedGoogle Scholar
  11. 11.
    Chang CF, Chen SF, Lee TS, Lee HF, Chen SF, Shyue SK (2011) Caveolin-1 deletion reduces early brain injury after experimental intracerebral hemorrhage. Am J Pathol 178:1749–1761CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Chen-Roetling J, Cai Y, Regan RF (2014) Neuroprotective effect of heme oxygenase-2 knockout in the blood injection model of intracerebral hemorrhage. BMC Res Notes 7:561–564CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Hoepken HH, Korten T, Robinson SR, Dringen R (2004) Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 88:1194–1202CrossRefPubMedGoogle Scholar
  14. 14.
    Wu H, Wu T, Xu X, Wang J (2010) Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab 31:1243–1250CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Masuda T, Hida H, Kanda Y, Aihara N, Ohta K, Yamada K, Nishino H (2007) Oral administration of metal chelator ameliorates motor dysfunction after a small hemorrhage near the internal capsule in rat. J Neurosci Res 85:213–222CrossRefPubMedGoogle Scholar
  16. 16.
    Klouche K, Morena M, Canaud B, Descomps B, Beraud JJ, Cristol JP (2004) Mechanism of in vitro heme-induced LDL oxidation: effects of antioxidants. Eur J Clin Invest 34:619–625CrossRefPubMedGoogle Scholar
  17. 17.
    González-Reyes S, Guzmán-Beltrán S, Medina-Campos ON, Pedraza-Chaverri J (2013) Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxidative Med Cell Longev 7:1–14CrossRefGoogle Scholar
  18. 18.
    Owen JE, Bishop GM, Robinson SR (2014) Phenanthrolines protect astrocytes from hemin without chelating iron. Neurochem Res 39:693–699CrossRefPubMedGoogle Scholar
  19. 19.
    Bishop GM, Dang TN, Dringen R, Robinson SR (2010) Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia. Neurotox Res 19:1–9Google Scholar
  20. 20.
    Tulpule K, Robinson SR, Bishop GM, Dringen R (2010) Uptake of ferrous iron by cultured rat astrocytes. J Neurosci Res 88:563–571PubMedGoogle Scholar
  21. 21.
    Meguro R, Asano Y, Odagiri S, Li C, Iwatsuki H, Shoumura K (2007) Nonheme-iron histochemistry for light and electron microscopy: a historical, theoretical and technical review. Arch Histol Cytol 70:1–19CrossRefPubMedGoogle Scholar
  22. 22.
    Hamprecht B, Loffler F (1985) Primary glial cultures as a model for studying hormone action. Methods Enzymol 109:341–345CrossRefPubMedGoogle Scholar
  23. 23.
    Dringen R, Kussmaul L, Hamprecht B (1998) Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by microtiter plate assay. Brain Res Protoc 2:223–228CrossRefGoogle Scholar
  24. 24.
    Riemer J, Hoepken HH, Czerwinska H, Robinson SR, Dringen R (2004) Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal Biochem 331:370–375CrossRefPubMedGoogle Scholar
  25. 25.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  26. 26.
    Edwards MM, Robinson SR (2006) TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer’s disease. J Neural Transm 113:1709–1715CrossRefPubMedGoogle Scholar
  27. 27.
    Regan RF, Wang Y, Xin M, Chong A, Guo Y (2001) Activation of extracellular signal-regulated kinases potentiates hemin toxicity in astrocyte cultures. J Neurochem 79:545–555CrossRefPubMedGoogle Scholar
  28. 28.
    Halliwell B, Gutteridge J (2007) Free radicals in biology and medicine. Oxford University Press, New YorkGoogle Scholar
  29. 29.
    Kruszewski M (2003) Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res Fundam Mol Mech Mutagen 531:81–92CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Jessica E. Owen
    • 1
  • Glenda M. Bishop
    • 1
  • Stephen R. Robinson
    • 1
  1. 1.School of Health SciencesRMIT UniversityBundooraAustralia

Personalised recommendations